Velars-sur-Ouche, France

Christiane Legendre

This inventor holds 1 USPTO granted patent. Top assignee: Fournier Industrie Et Sante. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christiane Legendre. Retrieved from https://idiyas.com/inventor/christiane-legendre-7my9ftas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Christiane Legendre

Introduction

Christiane Legendre is a notable inventor based in Velars-sur-Ouche, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have potential therapeutic applications.

Latest Patents

One of her key patents is titled "Derivatives of α-D-Thioxyloside and their use against atheroma." This invention concerns new industrial products, specifically the α-D-xylose compounds of formula I. Her work in this area highlights her commitment to advancing medical science and improving health outcomes.

Career Highlights

Christiane Legendre has established herself as a prominent figure in her field. She is associated with Fournier Industrie Et Sante, where she continues to innovate and contribute to the development of new pharmaceutical products. Her expertise and dedication have earned her recognition among her peers.

Collaborations

Throughout her career, Christiane has collaborated with talented individuals such as Alan Dunlap Edgar and Veronique Barberousse. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Christiane Legendre's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the area of atheroma treatment, demonstrate her commitment to improving health through scientific advancement.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…